Proceedings of a workshop on DNA adducts: Biological significance and applications to risk assessment Washington, DC, April 13-14, 2004

Toxicology and Applied Pharmacology

Volumn 208, Issue 1, 2005, Pages 1-20

  Sander, Miriam ^a   Cadet, Jean ^b   Casciano, Daniel A ^c   Galloway, Sheila M ^d   Marnett, Lawrence J ^e   Novak, Raymond F ^f   Pettit, Syril D ^g   Preston, R Julian ^h   Skare, Julie A ⁱ   Williams, Gary M ^j   Van Houten, Bennett ^k   Gollapudi, B Bhaskar ^l  

^a Page One Editorial Services   (United States)

^b DIF   (France)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f WAYNE STATE UNIVERSITY   (United States)

^g ILSI HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE   (United States)

^h U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

ⁱ PROCTER AND GAMBLE COMPANY   (United States)

^j NEW YORK MEDICAL COLLEGE   (United States)

^k NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^l DOW CHEMICAL COMPANY   (United States)

more..

Author keywords

DNA; DNA adducts; DNA damage; Risk assessment; Workshop report

Indexed keywords

1,4 DICHLOROBENZENE; ACRYLAMIDE; AGRICULTURAL CHEMICAL; AMITROLE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CARCINOGEN; CELL DNA; FOOD ADDITIVE; KOJIC ACID; LIMONENE; MUTAGENIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEOTIDE; PEPTIDE DERIVATIVE; RALOXIFENE; STEROID; TAMOXIFEN; THIOURACIL;

BREAST CANCER; CANCER RISK; CELL METABOLISM; CHEMOPROPHYLAXIS; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; DNA ADDUCT; DNA DAMAGE; DNA REPAIR; ENDOMETRIUM CANCER; GENE EXPRESSION; GENOMIC INSTABILITY; GENOMICS; GENOTOXICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL RESEARCH; NONHUMAN; RISK ASSESSMENT; TANDEM MASS SPECTROMETRY; TISSUE SPECIFICITY;

ANIMALS; BIOLOGICAL MARKERS; DNA ADDUCTS; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; HUMANS; RISK ASSESSMENT;

EID: 24744458369     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2004.12.012     Document Type: Conference Paper

References (77)

1. S.A. Amundson, K.T. Do, S. Shahab, M. Bittner, P. Meltzer, J. Trent, and A.J. Fornace Jr. Identification of potential mRNA markers in peripheral blood lymphocytes for human exposure to ionizing radiation Radiat. Res. 154 2000 342 346
2. S.A. Amundson, T.G. Myers, D. Scudiero, S. Kitada, J.C. Reed, and A.J. Fornace Jr. An informatics approach identifying markers of chemosensitivity in human cancer cell lines Cancer Res. 60 2000 6101 6110
3. S.A. Amundson, R.A. Lee, C.A. Koch-Paiz, M.L. Bittner, P. Meltzer, J.M. Trent, and A.J. Fornace Jr. Differential responses of stress genes to low dose-rate gamma-irradiation Mol. Cancer Res. 1 2003 445 452
4. V.M. Arlt, H. Glatt, E. Muckel, U. Pabel, B.L. Sorg, A. Seidel, H. Frank, H.H. Schmeiser, and D.H. Phillips Activation of 3-nitrobenzanthrone and its metabolites by human acetyltransferases, sulfotransferases and cytochrome P450 expressed in Chinese hamster V79 cells Int. J. Cancer 105 2003 583 592
5. V.M. Arlt, B.L. Sorg, M. Osborne, A. Hewer, A. Seidel, H.H. Schmeiser, and D.H. Phillips DNA adduct formation by the ubiquitous environmental pollutant 3-nitrobenzanthrone and its metabolites in rats Biochem. Biophys. Res. Commun. 300 2003 107 114
6. V.M. Arlt, L. Zhan, H.H. Schmeiser, M. Honma, M. Hayashi, D.H. Phillips, and T. Suzuki DNA adducts and mutagenic specificity of the ubiquitous environmental pollutant 3-nitrobenzanthrone in Muta mouse Environ. Mol. Mutagen. 43 2004 186 195
7. W.M. Baird, and B. Mahadevan The uses of carcinogen-DNA adduct measurement in establishing mechanisms of mutagenesis and in chemoprevention Mutat. Res. 547 2004 1 4
8. A. Barbin Etheno-adduct-forming chemicals: from mutagenicity testing to tumor mutation spectra Mutat. Res. 462 2000 55 69
9. A. Barbin, H. Ohgaki, J. Nakamura, M. Kurrer, P. Kleihues, and J.A. Swenberg Endogenous deoxyribonucleic acid (DNA) damage in human tissues: a comparison of ethenobases with aldehydic DNA lesions Cancer Epidemiol., Biomarkers Prev. 11 Pt 1 2003 1241 1247
10. 6-ethenoadenine in DNA is not associated with higher susceptibility to carcinogenesis in alkylpurine-DNA-N-glycosylase knockout mice treated with vinyl carbamate Cancer Res. 63 2003 7699 7703
11. T.J. Begley, A.S. Rosenbach, T. Ideker, and L.D. Samson Damage recovery pathways in Saccharomyces cerevisiae revealed by genomic phenotyping and interactome mapping Mol. Cancer Res. 1 2002 103 112
12. 32P-postlabeling analyses of tamoxifen-DNA adducts in humans J. Natl. Cancer Inst. 96 14 2004 1099 1104
13. M.E. Boerrigter, M.E. Dollé, H.J. Martus, J.A. Gossen, and J. Vijg Plasmid-based transgenic mouse model for studying in vivo mutations Nature 377 1995 657 659
14. J. Cadet, T. Douki, D. Gasparutto, and J.-L. Ravanat Oxidative damage to DNA: formation, measurement and biochemical features Mutat. Res. 531 2003 5 23
15. C.C. Capen E. Dybing J.M. Rice J.D. Wilbourn Species differences in thyroid, kidney and urinary bladder carcinogenesis (IARC Scientific Publications No. 147) 1999 IARC Press Lyon
16. A.R. Collins, J. Cadet, L. Möller, H.E. Poulsen, and J. Viña Are we sure we know how to measure oxidative base damage to DNA in human cells? Arch. Biochem. Biophys. 423 2004 57 65
17. G.A. Csanády, B. Denk, C. Putz, P.E. Kreuzer, W. Kessler, C. Baur, M.L. Gargas, and J.G. Filser A physiological toxicokinetic model for exogenous and endogenous ethylene and ethylene oxide in rat, mouse and human: formation of 2-hydroxyethyl adducts of hemoglobin and DNA Toxicol. Appl. Pharmacol. 165 2000 1 26
18. 6-carboxymethyl-2′-deoxyguanosine in DNA following reaction of nitric oxide with glycine and in human blood DNA using a quantitative immunoslot blot assay Chem. Res. Toxicol. 17 2004 294 300
19. M.E. Dollé, and J. Vijg Genome dynamics in aging mice Genome Res. 12 11 2002 November 1732 1738
20. M.E. Dollé, H. Giese, C.L. Hopkins, H.J. Martus, J.M. Hausdorff, and J. Vijg Rapid accumulation of genome rearrangements in liver but not in brain of old mice Nat. Genet. 17 1997 431 434
21. M.E. Dollé, W.K. Snyder, J.A. Gossen, P.H. Lohman, and J. Vijg Distinct spectra of somatic mutations accumulated with age in mouse heart and small intestine Proc. Natl. Acad. Sci. U.S.A. 97 2000 8403 8408
22. P.A. Egner, J.B. Wang, Y.R. Zhu, B.C. Zhang, Y. Wu, Q.N. Zhang, G.S. Qian, S.Y. Kuang, S.J. Gange, L.P. Jacobson, K.J. Helzlsouer, G.S. Bailey, J.D. Groopman, and T.W. Kensler Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer Proc. Natl. Acad. Sci. U.S.A. 98 2001 14601 14606
23. L. Ehrenberg, S. Osterman-Golkar, D. Segerbck, K. Svensson, and C.J. Calleman Evaluation of genetic risks of alkylating agents. III. Alkylation of haemoglobin after metabolic conversion of ethene to ethene oxide in vivo Mutat. Res. 45 1977 175 184
24. European Standards Committee on Oxidative DNA Damage (ESCODD) Comparative analysis of baseline 8-oxo-7,8-dihydroguanine in mammalian cell DNA, by different methods in different laboratories: an approach to consensus Carcinogenesis 23 2002 2129 2133
25. European Standards Committee on Oxidative DNA Damage (ESCODD) Measurement of DNA oxidation in human cells by chromatographic and enzymic methods Free Radical Biol. Med. 34 2003 1089 1099
26. J.G. Filser, B. Denk, M. Törnqvist, W. Kessler, and L. Ehrenberg Pharmacokinetics of ethylene in man; body burden with ethylene oxide and hydroxyethylation of hemoglobin due to endogenous and environmental ethylene Arch. Toxicol. 66 1993 157 163
27. S. Fukushima, H. Wanibuchi, K. Morimura, M. Wei, D. Nakae, Y. Konishi, H. Tsuda, N. Uehara, K. Imaida, T. Shirai, M. Tatematsu, T. Tsukamoto, M. Hirose, F. Furukawa, K. Wakabayashi, and Y. Totsuka Lack of a dose-response relationship for carcinogenicity in the rat liver with low doses of 2-amino-3,8- dimethylimidazo[4,5-f]quinoxaline or N-nitrosodiethylamine Jpn. J. Cancer Res. 93 2002 1076 1082
28. G. Gamboa da Costa, M.M Marques, F.A. Beland, J.P. Freeman, M.I. Churchwell, and D.R. Doerge Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry Chem. Res. Toxicol. 16 2003 357 366
29. G. Gamboa da Costa, M.I. Churchwell, L.P. Hamilton, L.S. Von Tungeln, F.A. Beland, M.M. Marques, and D.R. Doerge DNA adduct formation from acrylamide via conversion to glycidamide in adult and neonatal mice Chem. Res. Toxicol. 16 2003 1328 1337
30. K. Gorlewska, B. Green, M. Fares, C.B. Ambrosone, and F.F. Kadlubar A carcinogen-DNA adduct in human breast epithelial cells Environ. Mol. Mutagen. 39 2002 184 192
31. K.M. Gorlewska, B.L. Green, M. Fares, C.B. Ambrosone, and F.F. Kadlubar Carcinogen-DNA adducts in human breast epithelial cells Proc. Am. Assoc. Cancer Res. 43 2002 5043
32. J.D. Groopman, and T.W. Kensler The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight? Carcinogenesis 20 1999 1 11
33. J.D. Groopman, B.D. Roebuck, and T.W. Kensler Application of monoclonal antibodies and dietary antioxidant-based animal models to define human exposure to aflatoxin B1 Prog. Exp. Tumor Res. 31 1987 52 62
34. Y. Guichard, F. El Ghissassi, J. Nair, H. Barstch, and A. Barbin Formation and accumulation of DNA ethenobases in adult Sprague-Dawley rats exposed to vinyl chloride Carcinogenesis 17 1996 1553 1559
35. 6-etheno- deoxyadenosine DNA lesions from lung and liver in vivo DNA Repair (Amst) 3 2004 257 265
36. K. Hemminki, and W.G. Thilly Implications of results of molecular epidemiology on DNA adducts, their repair and mutations for mechanisms of human cancer IARC Sci. Publ. 157 2004 217 235
37. W.K. Huh, J.V. Falvo, L.C. Gerke, A.S. Carroll, R.W. Howson, J.S. Weissman, and E.K. O'Shea Global analysis of protein localization in budding yeast Nature 425 2003 686 691
38. IARC Some Industrial Chemicals IARC Monographs on the Evaluation of Carcinogenic Risks to Humans vol. 60, 45-71 1994 IARC Press Lyon 73 160
39. IARC IARC monographs on the evaluation of carcinogenic risks to humans Some chemicals that cause tumours of the kidney or urinary bladder in rodents and some other substances vol. 73 1999 IARC Press Lyon
40. IARC IARC monographs on the evaluation of carcinogenic risks to humans Some thyrotropic agents vol. 79 2001 IARC Press Lyon
41. ICH S2A Technical Requirements for Registration of Pharmaceuticals for Human Use Genotoxicity: guidance on specific aspects of regulatory genotoxicity tests for pharmaceuticals Fed. Regist. 61 1996 18198 18202
42. ICH S2B Technical Requirements for Registration of Pharmaceuticals for Human Use Genotoxicity: a standard battery for genotoxicity testing of pharmaceuticals Fed. Regist. 62 1997 16026 16030
43. P.E. Jackson, S.Y. Kuang, J.B. Wang, P.T. Strickland, A. Munoz, T.W. Kensler, G.S. Qian, and J.D. Groopman Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients Carcinogenesis 24 2003 1657 1663
44. A. Jacobs, and D. Jacobson-Kram Human carcinogenic risk evaluation, Part III: Assessing cancer hazard and risk in human drug development Toxicol. Sci. 81 2 2004 260 262 (Electronic publication 2004 May 12)
45. A.M. Jeffrey, F.Q. Luo, S. Amin, J. Krzeminski, K. Zech, and G.M. Williams Lack of DNA binding in the rat nasal mucosa and other tissues of the nasal toxicant roflumilast, a phosphodiesterase 4 inhibitor, and a metabolite, 4-amino-3,5-dichloro-pyridine, in contrast to the nasal carcinogen 2,6-dimethylaniline Drug Chem. Toxicol. 25 2002 93 107
46. T.W. Kensler, P.A. Egner, N.E. Davidson, B.D. Roebuck, A. Pikul, and J.D. Groopman Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases Cancer Res. 46 1986 3924 3931
47. T.W. Kensler, G.S. Qian, J.G. Chen, and J.D. Groopman Translational strategies for cancer prevention in liver Nat. Rev., Cancer 3 2003 321 329 (Review)
48. S.Y. Kuang, P.E. Jackson, J.B. Wang, P.X. Lu, A. Munoz, G.S. Qian, T.W. Kensler, and J.D. Groopman Specific mutations of hepatitis B virus in plasma predict liver cancer development Proc. Natl. Acad. Sci. U.S.A. 101 2004 3575 3580
49. J. Nakamura, E.R. Purvis, and J.A. Swenberg Micromolar concentrations of hydrogen peroxide induce oxidative DNA lesions more efficiently than millimolar concentrations in mammalian cells Nucleic Acids Res. 31 2003 1790 1795
50. P. Neven, S.R. Goldstein, A.V. Ciaccia, L. Zhou, S.L. Silfen, and D. Muram The effect of raloxifene on the incidence of ovarian cancer in postmenopausal women Gynecol. Oncol. 85 2002 388 390
51. M. Otteneder, and W.K. Lutz Correlation of DNA adduct levels with tumor incidence: carcinogenic potency of DNA adducts Mutat. Res. 424 1999 237 247
52. D.H. Phillips, P.B. Farmer, F.A. Beland, R.G. Nath, M.C. Poirier, M.V. Reddy, and K.W. Turteltaub Methods of DNA adduct determination and their application to testing compounds for genotoxicity Environ. Mol. Mutagen. 35 2000 222 233
53. M.C. Poirer Chemical-induced DNA damage and human cancer risk Nat. Rev., Cancer 4 2004 630 637
54. J.-P. Pouget, S. Frelon, J.-L. Ravanat, I. Testard, F. Odin, and J. Cadet Formation of modified bases to DNA in cells exposed to either gamma radiation or high-LET particles Radiat. Res. 157 2002 589 595
55. A.K. Prahalad, J.A. Ross, G.B. Nelson, B.C. Roop, L.C. King, S. Nesnow, and M.J. Mass Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung Carcinogenesis 18 1997 1955 1963
56. R.J. Preston Molecular epidemiology: potential impacts on the assessment of public health Mutat. Res. 543 2003 121 124
57. M.V. Reddy, R.D. Storer, G.M. Laws, M.J. Armstrong, J.E. Barnum, J.P. Gara, C.G. McKnight, T.R. Skopek, J.F. Sina, J.G. DeLuca, and S.M. Galloway Genotoxicity of naturally occurring indole compounds: correlation between covalent DNA binding and other genotoxicity tests Environ. Mol. Mutagen. 40 2002 1 17
58. K.A. Risma, C.M. Clay, T.M. Nett, T. Wagner, J. Yun, and J.H. Nilson Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors Proc. Natl. Acad. Sci. U.S.A. 92 1995 1322 1326
59. J.A. Ross, G.B. Nelson, K.H. Wilson, J.R. Rabinowitz, A. Galati, G.D. Stoner, and S. Nesnow Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels Cancer Res. 55 1995 1039 1044
60. S. Shibutani, A. Ravindernath, N. Suzuki, I. Terashima, S.M. Sugarman, A.P. Grollman, and M.L. Pearl Identification of tamoxifen-DNA adducts in the endometrium of women treated with tamoxifen Carcinogenesis 21 2000 1461 1467
61. S. Shibutani, A. Ravindernath, I. Terashima, N. Suzuki, Y.R. Laxmi, Y. Kanno, M. Suzuki, T.I. Apak, J.J. Sheng, and M.W. Duffel Mechanism of lower genotoxicity of toremifene compared with tamoxifen Cancer Res. 61 2001 3925 3931
62. S. Shibutani, N. Suzuki, Y.R. Laxmi, L.J. Schild, R.L. Divi, A.P. Grollman, and M.C. Poirier Identification of tamoxifen-DNA adducts in monkeys treated with tamoxifen Cancer Res. 63 2003 4402 4406
63. H.A. Schut, D.A. Cummings, M.H. Smale, S. Josyula, and M.D. Friesen DNA adducts of heterocyclic amines: formation, removal and inhibition by dietary components Mutat. Res. 376 1997 185 194
64. H.A. Schut, C.L. Wang, L.M. Twining, and K.M. Earle Formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in CDF1 mice fed a high omega-3 fatty acid diet Mutat. Res. 378 1997 23 30
65. 32P-postlabeling/ polyacrylamide gel electrophoresis analysis; application to the detection of DNA adducts Chem. Res. Toxicol. 15 2002 305 311
66. M. Tornqvist Ethylene oxide as a biological reactive intermediate of endogenous origin Adv. Exp. Med. Biol. 387 1996 275 283
67. R.J. Turesky, J.P. Freeman, R.D. Holland, D.M. Nestorick, D.W. Miller, D.L. Ratnasinghe, and F.F. Kadlubar Identification of aminobiphenyl derivatives in commercial hair dyes Chem. Res. Toxicol. 16 2003 1162 1173
68. J. Vijg Somatic mutations and aging: a re-evaluation Mutat. Res. 447 2000 117 135
69. J. Vijg, and M.E. Dollé Large genome rearrangements as a primary cause of aging Mech. Ageing Dev. 123 2002 907 915
70. W.J. Waddell, N.H. Crooks, and P.L. Carmichael Correlation of tumors with DNA adducts from methyleugenol and tamoxifen in rats Toxicol. Sci. 79 2004 38 40
71. 32P-postlabeling analysis of the formation and persistence of DNA adducts in mammary glands of parous and nulliparous mice treated with benzo[a]pyrene Carcinogenesis 13 1992 2009 2015
72. V.E. Walker, K.Y. Wu, P.B. Upton, A. Ranasinghe, N. Scheller, M.H. Cho, J.S. Vergnes, T.R. Skopek, and J.A. Swenberg Biomarkers of exposure and effect as indicators of potential carcinogenic risk arising from in vivo metabolism of ethylene to ethylene oxide Carcinogenesis 21 2000 1661 1669
73. J.S. Wang, X. Shen, X. He, Y.R. Zhu, B.C. Zhang, J.B. Wang, G.S. Qian, S.Y. Kuang, A. Zarba, P.A. Egner, L.P. Jacobson, A. Munoz, K.J. Helzlsouer, J.D. Groopman, and T.W. Kensler Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China J. Natl. Cancer Inst. 91 1999 347 354
74. R.E. Watson, and J.I. Goodman Epigenetics and DNA methylation come of age in toxicology Toxicol. Sci. 67 2002 11 16
75. W. Willemson, R. Kruitwagan, B. Bastiaans, T. Hanselaar, and R. Rolland Ovarian stimulation and granulosa-cell tumour Lancet 341 1993 986 988
76. G.M. Williams, M.J. Iatropoulos, and A.M. Jeffrey Mechanistic basis for nonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine Toxicol. Pathol. 28 2000 388 395
77. G.M. Williams, M.J. Iatropoulos, and A.M. Jeffrey Thresholds for the effects of 2-acetylaminofluorene in rat liver Toxicol. Pathol. 32 Suppl. 2 2004 85 91